Highbridge Capital Management’s Imperva, Inc. IMPV Stock Holding History

Highbridge Capital Management’s Portfolio IMPV Stock Details IMPV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-102,861	Closed	-$4.96M	–	1014
2018 Q2	$4.96M	Sell	102,861 -68,237	-40%	-$3.26M	0.1%	250
2018 Q1	$7.41M	Buy	171,098 +163,007	+2,015%	+$7.32M	0.12%	217
2017 Q4	$321K	Buy	+8,091	New	+$337K	0.01%	1194
2017 Q3	–	Sell	-7,478	Closed	-$358K	–	1925
2017 Q2	$358K	Buy	7,478 +12	+0.2%	+$560	0.01%	889
2017 Q1	$306K	Buy	+7,466	New	+$312K	﹤0.01%	1131
2016 Q4	–	Sell	-162,518	Closed	-$8.73M	–	1764
2016 Q3	$8.73M	Buy	162,518 +79,832	+97%	+$3.71M	0.14%	171
2016 Q2	$3.56M	Buy	+82,686	New	+$3.47M	0.06%	325
2016 Q1	–	Sell	-105,098	Closed	-$5.06M	–	1991
2015 Q4	$6.65M	Buy	+105,098	New	+$7.16M	0.1%	230
2015 Q1	–	Sell	-12,043	Closed	-$595K	–	1704
2014 Q4	$595K	Buy	+12,043	New	+$482K	0.01%	775
2013 Q4	–	Sell	-12,532	Closed	-$526K	–	1442
2013 Q3	$526K	Buy	+12,532	New	+$597K	0.01%	867

Other funds holding IMPV

Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return

EMG

ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Highbridge Capital Management's IMPV Position: Q3 2018 in Review

Highbridge Capital Management sold out of Imperva, Inc. (IMPV) in Q3 2018, closing a stake of 102,861 shares — an estimated $4.96M sold.

Highbridge Capital Management first reported a position in IMPV in Q3 2013 and held it in 10 quarters. The position peaked at $8.73M in Q3 2016. 168 funds tracked by Wall St. Rank hold IMPV as of Q3 2018.

Highbridge Capital Management reported no remaining Imperva, Inc. position as of Q3 2018 after selling out during the quarter.
Highbridge Capital Management sold 102,861 Imperva, Inc. shares in Q3 2018, an estimated $4.96M.
Highbridge Capital Management first reported a position in Imperva, Inc. in Q3 2013 and held it in 10 quarters.
Highbridge Capital Management's Imperva, Inc. position peaked at $8.73M in Q3 2016.
168 funds tracked by Wall St. Rank held Imperva, Inc. as of Q3 2018.

Based on Highbridge Capital Management's 13F filing for Q3 2018, filed 13 Nov 2018.